Do you or someone you know suspect Tick Borne Illness?
Recent Advancements in Testing Allow For Greater Detection
A POSITION ON DIAGNOSTIC TESTING FROM THE INTERNATIONAL AND ASSOCIATED DISEASE SOCIETY (ILADS):
Lyme disease is a clinical diagnosis based on the history and physical findings, and supported by appropriate laboratory tests when they are indicated. These elements must be considered in the context of the individual patient’s full story and with consideration of other diagnoses that may explain or confound the patient’s diagnosis. No single element of the diagnostic process outweighs the full and complete evaluation. The strengths and limitations of laboratory testing must be understood by the clinician in order to use testing modalities effectively and avoid some of the pitfalls of diagnosis that can result from over-reliance on laboratory testing to rule in or rule out an illness.
-
![]()
IgeneX
Tick-borne diseases are quickly spreading across the US. Lyme disease is one of the fastest-growing infectious diseases in the United States. Around 475,000 people are diagnosed with Lyme disease annually in the US. Unfortunately, many of these diseases share similar symptoms and are difficult to detect without testing.
IGeneX is a CLIA certified lab with over 30 years of experience that offers comprehensive testing for major tick-borne diseases, ensuring that physicians provide the correct diagnosis to patients and helps them get the treatment that will be most effective.
IGeneX is a fully certified high-complexity testing lab specializing in Lyme and other tick-borne disease testing.
-
![]()
Galaxy Diagnostics
Galaxy Diagnostics, Inc. provides highly sensitive, enhanced detection of vector-borne infections using optimized direct and indirect detection test methods including sample enrichment, liquid culture, PCR, and serology. We perform diagnostic assays for both Animal Health and Human Health under strict quality control testing standards in a COLA accredited CLIA laboratory (COLA 23168; CLIA 34D2027997; PDH 32300; DHMH 1828; COS 800375). We follow exemplary laboratory practices regarding personnel qualifications and experience, facility and equipment maintenance, and protocol validation as defined by federal regulations governing laboratory testing for human health in the United States
-
![]()
Vibrant Wellness
Tickborne diseases are rising throughout the US from a variety of ticks, which carry and pass on different microorganisms to humans and animals. Tickborne diseases have more than doubled in 13 years and represent 77% of all vector-borne disease reports. Lyme disease accounts for 82% of all cases.
The Lyme Autoimmune panel tests for antibodies against specific antigens related to Lyme disease that are known to trigger autoimmune conditions, focusing on arthritis, carditis, and neuroborreliosis.
The test’s unique approach combines the assessment of specific antigens and their interaction with the immune system, providing valuable insights into the pathogenesis and management of these complex conditions. -
![]()
T Lab Inc
T Lab Inc (TLab) is breaking new ground in revealing the mechanisms of inflammation. We are a CAP Accredited and CLIA-certified clinical laboratory, developing new levels of microscopic imaging to identify the presence of pathogens in blood, and exploring the causes and consequences of inflammatory disease. Many of these infections may be due to vector borne diseases such as Borrelia (Lyme), Bartonella and Babesia species. We have unique expertise and tests to do this reliably and efficiently, supported by a great team of experts.
Certifications & Accreditation
We are a CAP accredited and CLIA certified laboratory.– College of American Pathologists (CAP) 8851753
– CLIA Certificate 21D2062544
– MD Lab Permit 130267
– California Lab License COS-90010599
-
![]()
Moleculara Biosciences
Treatment resistant symptoms
As many as 60% of patients worldwide suffering from neurologic, psychiatric and behavioral disorders do not respond to treatment. Now, there is growing evidence indicating that, in some of these cases, treatment resistance may be due to an undiagnosed immune dysfunction, triggered by infection(s).
